Bruce G. Allen Investments’s 10x Genomics TXG Stock Holding History

Bruce G. Allen Investments’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.33K	Hold	113	–	–	﹤0.01%	591
2026 Q1	$2.4K	Hold	113	–	–	﹤0.01%	670
2025 Q4	$1.84K	Hold	113	–	–	﹤0.01%	710
2025 Q3	$1.32K	Hold	113	–	–	﹤0.01%	768
2025 Q2	$1.31K	Buy	113 +61	+117%	+$556	﹤0.01%	777
2025 Q1	$454	Buy	+52	New	+$656	﹤0.01%	962
2024 Q4	–	Sell	-49	Closed	-$1.11K	–	1146
2024 Q3	$1.11K	Sell	49 -114	-70%	-$2.36K	﹤0.01%	802
2024 Q2	$3.17K	Buy	163 +137	+527%	+$3.59K	﹤0.01%	626
2024 Q1	$976	Hold	26	–	–	﹤0.01%	783
2023 Q4	$1.46K	Buy	+26	New	+$1.13K	﹤0.01%	792

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bruce G. Allen Investments's TXG Position: Q2 2026 in Review

Bruce G. Allen Investments held its 10x Genomics (TXG) position steady in Q2 2026 at 113 shares worth $4.33K. The position accounts for ﹤0.01% of the portfolio, ranked #591.

Bruce G. Allen Investments first reported a position in TXG in Q4 2023 and has held it in 10 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Bruce G. Allen Investments held 113 shares of 10x Genomics worth $4.33K as of Q2 2026.
Bruce G. Allen Investments left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #591 holding.
Bruce G. Allen Investments first reported a position in 10x Genomics in Q4 2023 and has held it in 10 quarters since.
393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.